Innate Pharma S.A. (IPHA)
NASDAQ: IPHA · Real-Time Price · USD
1.820
-0.080 (-4.21%)
Jun 25, 2026, 10:14 AM EDT - Market open
Innate Pharma Market Cap
Innate Pharma has a market cap or net worth of $176.92 million as of June 25, 2026. Its market cap has decreased by -0.21% in one year.
Market Cap
176.92M
Enterprise Value
163.58M
1-Year Change
-0.21%
Ranking
Category
Stock Price
$1.82
Market Cap Chart
Since October 18, 2019, Innate Pharma's market cap has decreased from $480.08M to $176.92M, a decrease of -63.15%. That is a compound annual growth rate of -13.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 24, 2026 | 176.92M | 2.04% |
| Dec 31, 2025 | 173.38M | 4.71% |
| Dec 31, 2024 | 165.58M | -29.08% |
| Dec 29, 2023 | 233.49M | -17.19% |
| Dec 30, 2022 | 281.97M | -29.50% |
| Dec 31, 2021 | 399.94M | 19.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LENZ Therapeutics | 181.23M |
| Equillium | 180.83M |
| Precision BioSciences | 180.36M |
| Milestone Pharmaceuticals | 178.91M |
| NovaBridge Biosciences | 176.36M |
| OnKure Therapeutics | 175.32M |
| Protalix BioTherapeutics | 175.24M |
| Turn Therapeutics | 173.22M |